Clara Baldari

Clara Baldari

Auto-generated profile, based on publicly available information

Clara Baldari

Department of Experimental Medicine University of Salento Lecce Italy

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 August 2026 in Advanced Healthcare Materials
Verified
Journal Article
Open access
PDF file
CBClara Baldari
Clara Baldari
CLClaudia Leone
Claudia Leone
GLGabriella Leccese
Gabriella Leccese
CSClaudia De Stradis
Claudia De Stradis
AIAlessandra Invidia
Alessandra Invidia
Ilaria Elena PalamàIlaria Elena Palamà
Ilaria Elena Palamà
Nonviral gene therapy reached unprecedented clinical prominence, with the approval of lipid nanoparticles (LNPs). Yet, their success remains largely confined to a narrow range of applications and tissues, which reflects the inherent functional constraints based on formulation optimization to overcome intrinsically complex physiological barriers. In contrast, biological membranes evolved to integrate immune evasion, targeting, intracellular trafficking, and membrane fusion within a single functional interface. In this review, we provide a mechanistic comparison between membrane‐derived vesicles (MDVs) and hybrid biomimetic systems. We critically examine MDVs from different biological sources, highlighting their unique advantages for gene delivery applications. We also focus on hybrid systems, which merge the biological functionality of naturally derived membranes with the design control of synthetic nanovectors to address key limitations such as inefficient cytosolic release, poor targeting specificity, and transfection of hard‐to‐engineer cells. This review provides a biologically informed roadmap for designing efficient gene delivery vectors, proposing membrane‐integrated nanovesicles (NVs) as “living interfaces” for non‐viral gene therapy.